Notices for publication in the OJ nº T-549/19 of Tribunal General de la Unión Europea, Friday September 20, 2019

• Resolution Date: Friday September 20, 2019
• Issuing Organization: Tribunal General de la Unión Europea
• Decision Number: T-549/19

Action brought on 8 August 2019 - Medac Gesellschaft für klinische Spezialpräparate v Commission

(Case T-549/19)

Language of the case: German

Parties

Applicant: Medac Gesellschaft für klinische Spezialpräparate mbH (Wedel, Germany) (represented by: P. von Czettritz, lawyer)

Defendant: European Commission

Form of order sought

The applicant claims that the Court should:

annul the contested decision;

order the European Commission to pay the costs.

Pleas in law and main arguments

The action is brought against Article 5 of Commission Implementing Decision of 20 June 2019 C92019) 4858 (final) granting a conditional marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council ¹ for ‘Trecondi - Treosulfan’, a medicinal product for human use.

In support of the action, the applicant relies on five pleas in law.

First plea in law, alleging that the contested decision is vitiated by a manifest error in law in so far as, in the interpretation of the concept of ‘satisfactory method’ for the purposes of Article 3(1)(b) of Regulation (EC) No 141/2000, ² data about Trecondi compared with...